Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Relish Pharmaceuticals

BSE: 524632|ISIN: INE551C01028|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 11, 16:00
43.00
0
VOLUME 80
Relish Pharmaceuticals is not listed on NSE
Announcements on Relish Pharma

14th-Nov-2017 18:40Source: BSE

Relish Pharmaceuticals- Financial Result For Quarter And Half Year Ended On 30Th September, 2017

The company is hereby submit outcome of the Board meeting held on today along with the Unaudited financial result for quarter and half year ended on 30th September, 2017 along with the limited review ...

6th-Nov-2017 18:53Source: BSE

Relish Pharmaceuticals- Closure of Trading Window

As per the Company''s Code of Conduct for Prohibition of Insider Trading, the trading window for dealing in the securities of the Company will be closed for all specified persons of the Company from 0...

6th-Nov-2017 18:52Source: BSE

Relish Pharmaceuticals- Board Meeting On 14Th September, 2017

The meeting of the Board of Directors of the Company will be held on 14th November, 2017 at 03:00 p.m. at the Registered Office of the Company to transact the following business:

1.To consid...

30th-Oct-2017 16:49Source: BSE

Relish Pharmaceuticals- Compliance With The Regulation 40(10) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015

The company is hereby submitted the Half Yearly compliance certificate for the half year ended September, 2017 in compliance in with the Regulation 40(10) of SEBI (Listing Obligation and Disclosure Re...

28th-Oct-2017 11:26Source: BSE

Relish Pharmaceuticals- Compliance Certificate For The Period Ended September, 2017.

The company is hereby submitted the Compliance Certificate for the half year ended as on 30th September, 2017

17th-Oct-2017 12:40Source: BSE

Relish Pharmaceuticals- Shareholding for the Period Ended September 30, 2017

Shukra Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly

17th-Oct-2017 11:34Source: BSE

Relish Pharmaceuticals- Statement Of Investor Complaints For The Quarter Ended September, 2017.

The company is hereby submitted the Statement of Investor Complaints for the quarter ended September, 2017

15th-Sep-2017 19:18Source: BSE

Relish Pharma- Revised Financial Result For The Quarter Ended As On 30Th June, 2017

The Company is hereby submitted the Revised Financial Result for the Quarter ended as on 30th June, 2017.

15th-Sep-2017 10:42Source: BSE

Relish Pharma- Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

Shukra Pharmaceuticals Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly

14th-Sep-2017 19:43Source: BSE

Relish Pharma- Submission Of Voting Result Along With Scrutinizer Report

Pursuant to Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015. the company is hereby sumbitted the voting result along with scrutinizer report of Annual...

1 2 3 4 5 Next >>
Quick Links for Relish Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.